Skip to main content

Dermatology and Therapy

Ausgabe 11/2023

Inhalt (31 Artikel)

Open Access Review

Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm

Rahul Masson, Charlotte Y. Jeong, Elaine Ma, Ashley B. Crew, Natalie M. Fragoso, Vivian Y. Shi, Jennifer L. Hsiao

Open Access Review

Topical Treatment for the Management of Mild-to-Moderate Psoriasis: A Critical Appraisal of the Current Literature

Maria Concetta Fargnoli, Clara De Simone, Paolo Gisondi, Giovanni Pellacani, Piergiacomo Calzavara-Pinton

Open Access Review

Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials

Hannah Penton, Sayeli Jayade, Santhani Selveindran, Marieke Heisen, Christophe Piketty, Liliana Ulianov, Zarif K. Jabbar-Lopez, Jonathan I. Silverberg, Jorge Puelles

Open Access Review

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status

Thomas B. Casale, Ana Maria Gimenez-Arnau, Jonathan A. Bernstein, Michael Holden, Torsten Zuberbier, Marcus Maurer

Open Access Original Research

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

April W. Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor Chirikov

Open Access Correction

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

April W. Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor Chirikov

Open Access Original Research

The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany

Maria Kahn, Steffeni Papukchieva, Elizabeth Jacyshyn-Owen, Stefan Grimm, Markus Eberl, Sebastian Schneeweiss, Marina Otten, Matthias Augustin, Benjamin Friedrich

Open Access Original Research

Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Diamant Thaçi, Christos Tziotzios, Taisuke Ito, Justin Ko, Ayşe Serap Karadağ, Hong Fang, Roger A. Edwards, Gianluca Bonfanti, Robert Wolk, Helen Tran, Ernest Law

Open Access Original Research

Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database

Joseph F. Merola, Dhaval Patil, Antton Egana, Andrea Steffens, Noah S. Webb, Alice B. Gottlieb

Open Access Original Research

Burden of Herpes Zoster Among Patients with Psoriasis in the United States

David Singer, Philippe Thompson-Leduc, Siyu Ma, Deepshekhar Gupta, Wendy Y. Cheng, Selvam R. Sendhil, Manasvi Sundar, Ella Hagopian, Nikita Stempniewicz, Mei Sheng Duh, Sara Poston

Open Access Original Research

Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study

Mehdi Sowlati, Silviu-Horia Morariu, Olguta Orzan, Stefano Veraldi, Roni P. Dodiuk-Gad, Remus I. Orasan, Cristian Gainaru

Open Access Original Research

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective

Jinsui Zhang, Zemin Xia, Wanjie Guo, Xiaoxiao Ren, Fang Liu, Gargi Ratnaparkhi, Amit Pagada, Subhashini Subramanian, Min Hu, Wen Chen

Open Access Original Research

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis

Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit

Open Access Original Research

Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2

Byung Soo Kim, Seong Jin Jo, SangWoong Youn, Kristian Reich, Carine Saadoun, Chia-Ling Chang, Ya-Wen Yang, Yu-Huei Huang, Tsen-Fang Tsai

Open Access Original Research

Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry

Robert R. McLean, Adam P. Sima, Silky Beaty, Robert Low, Rebecca L. Spitzer, Jeffrey L. Stark, Elizabeth Lesser, Edward Lee, April Armstrong

Open Access Original Research

Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry

Robert R. McLean, Adam P. Sima, Silky Beaty, Eric A. Jones, Thomas Eckmann, Robert Low, Laura McClung, Rebecca L. Spitzer, Jeffrey Stark, April Armstrong

Open Access Original Research

Thermal Therapy Modulation of the Psoriasis-Associated Skin and Gut Microbiome

Serena Manara, Francesco Beghini, Giulia Masetti, Federica Armanini, Davide Geat, Giulia Galligioni, Nicola Segata, Stefania Farina, Mario Cristofolini

Open Access Original Research

Neurotrophin-4 and Brain-Derived Neurotrophic Factor Serum Levels in Renal Transplant Recipients with Chronic Pruritus

Kinga Tyczyńska, Piotr K. Krajewski, Danuta Nowicka-Suszko, Dariusz Janczak, Hanna Augustyniak-Bartosik, Magdalena Krajewska, Jacek C. Szepietowski

Open Access Original Research

Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms

Ericles Andrei Bellei, André Vicente Esteves de Carvalho, Beatriz Magalhães Eng, Carla Tozato, Danilo Hamilko de Barros, Erika Yumi Tamashiro, Gleison Vieira Duarte, Rafael Toledo Rodrigues de Fátima, Renata Ferreira Magalhães, Roberto Souto da Silva, Wagner Guimarães Galvão Cesar, Felipe Garutti Thies

Open Access Original Research

Evaluating the Appropriateness of Existing Health-Related Quality of Life Measures in Lichen Planus

Aoife Mahon-Smith, George Skingley, Lara Ayala-Nunes, Anjali Batish, Rosie Sharp, Christel Naujoks, Eva Schruf, Nicolò Compagno, Santiago G. Moreno

Open Access Original Research

Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis

April W. Armstrong, Richard B. Warren, Yichen Zhong, Joe Zhuo, Allie Cichewicz, Ananth Kadambi, Daniela Junqueira, Tracy Westley, Renata Kisa, Carolin Daamen, Matthias Augustin

Open Access Brief Report

Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis

Ana-Maria Orbai, Soumya D. Chakravarty, Yin You, May Shawi, Ya-Wen Yang, Joseph F. Merola

Open Access Brief Report

Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data

Axel De Greef, Romane Thirion, Pierre-Dominique Ghislain, Marie Baeck

Open Access Brief Report

Responsiveness and Minimal Clinically Important Difference of the Infants and Toddlers Dermatology Quality of Life Questionnaire

Pavel V. Chernyshov, Servando E. Marron, Dimitra Koumaki, Nives Pustišek, Liana Manolache, Carmen Salavastru, Alina Suru, Adelina Sendrea, Tetiana Svyatenko, Olha Statkevych, Michael J. Boffa, Sara Borg Grech, Sergii Zemskov, Volodymyr V. Kuts, Pavlo Lishchynskyi, Andrii V. Chernyshov, Lucia Tomas-Aragones

Open Access Brief Report

Public Perceptions, Factors, and Incentives Influencing Patient Willingness to Share Clinical Images for Artificial Intelligence-Based Healthcare Tools

Sophia Ly, Sophia Reyes-Hadsall, Lara Drake, Guohai Zhou, Caroline Nelson, John S. Barbieri, Arash Mostaghimi

Open Access Brief Report

Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation

Riley K. Spencer, Joy Q. Jin, Kareem G. Elhage, Mitchell S. Davis, Marwa Hakimi, George Gondo, Wilson Liao, Tina Bhutani

Open Access Letter

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

Andrew Blauvelt, Alyssa Garrelts, William Malatestinic, Julie Birt, Baojin Zhu, Meghan Feely

Open Access Letter

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R. Feldman

Open Access Correction

Correction to: Real-World Treatment Patterns in Patients with Vitiligo in the United States

David Rosmarin, Ahmed M. Soliman, Chao Li

Open Access Correction

Correction to: Long-Term Effectiveness and Drug Survival of Secukinumab in Vietnamese Patients with Psoriasis: Results from a Retrospective ENHANCE Study

Hao Trong Nguyen, Nhi Thi Uyen Pham, Tu Nguyen Anh Tran, Nguyen Nhat Pham, Yen Thi Bui, Thao Thi Phuong Vu

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.